Frizzled-4 receptor complex (FZD4 complex)

The Frizzled-4 receptor complex is a specialized signaling assembly primarily composed of the Frizzled-4 (FZD4) receptor, the co-receptor Low-density lipoprotein receptor-related protein 5 (LRP5), and the essential auxiliary protein Tetraspanin-12 (TSPAN12) [PMID: 20159555, PMID: 19748355]. This complex specifically binds the ligand Norrin (NDP) to activate the canonical Wnt/beta-catenin signaling pathway, which is critical for the development and maintenance of the blood-retina barrier and vascularization of the inner ear [UniProt Q9ULV1, PMID: 15035039]. Unlike most Wnt receptors, this complex exhibits high specificity for Norrin, making it a key regulator of organ-specific angiogenesis. Mutations in any component of this complex are linked to severe vitreoretinal diseases, such as Norrie disease and Familial Exudative Vitreoretinopathy (FEVR), characterized by incomplete retinal vascularization and exudative retinal detachment [PMID: 22678063]. Therapeutically, the complex is targeted by agonists or Norrin mimetics to restore vascular stability in conditions like diabetic retinopathy and wet age-related macular degeneration. For example, bispecific antibodies like SZN-413 are designed to bridge FZD4 and LRP5 to mimic Norrin signaling and repair damaged ocular vasculature [Surrozen, 2023]. Because the pathway is highly specific to certain vascular beds, it offers a targeted approach to treating ocular diseases with potentially fewer systemic side effects than broad Wnt modulators [PMID: 30639423]. Monitoring for mutations in the constituent genes serves as a primary biomarker for patient selection in clinical settings.

Other names

Norrin-Frizzled-4-LRP5-TSPAN12 complexNDP-FZD4-LRP5-TSPAN12 signaling complexNorrin receptor complexNorrin pathway receptor complex

Agonism of the Frizzled-4 receptor complex to activate canonical Wnt signaling and restore vascular integrity.